A randomized superiority clinical trial: metronidazole improved the efficacy of high-dose dual therapy in Helicobacter pylori rescue treatment.

Zhao-Hui DingYu HuangJin-Nan ChenLai-Sheng LuoWei ZhangXiao LiangHong Lu

Published in: The Journal of antimicrobial chemotherapy (2023)

A triple therapy containing high dose of PPI and amoxicillin plus metronidazole could be a potential rescue therapy worldwide even in a high metronidazole-resistance region.

Keyphrases

high dose
helicobacter pylori
clinical trial
randomized controlled trial
stem cells
risk assessment
mesenchymal stem cells
cell therapy
open label
replacement therapy
phase ii